Chimeric switch-receptor PD1-DAP10-41BB augments NK92 cell antitumor activity June 3, 2022 No Comments
Chemokine-targeting B7-H3.CAR-T cells show enhanced activity against NSCLC brain tumor lesions May 27, 2022 No Comments
Ellipses Pharma licenses rights to SunRock's bifunctional HER3:TRAIL fusion protein May 26, 2022 No Comments
CureVac and myNEO enter research and option agreement toward development of mRNA cancer vaccines May 26, 2022 No Comments
Elicio shows AMP vaccination significantly enhances TCR-T antitumor response in tumor model May 24, 2022 No Comments
Research on IL-38 mRNA expression in cancers supports Immunome's development of IMM-ONC-01 May 24, 2022 No Comments
Aptamer and PinotBio extend collaboration to develop Optimer-drug conjugates May 24, 2022 No Comments
RSS